Trials / Unknown
UnknownNCT05977543
Acute Effect of Functional Crackers on Postprandial Metabolism
The Acute Effect of Functional Crackers, Enriched With Grape Seed Flour or With Barley Flour and β-glucans, on Postprandial Glycemic, Lipemic and Antioxidant Metabolism
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of the Aegean · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this interventional study was to investigate the postprandial effect of two types of functional crackers, with 10% grape seed flour or 40% barley flour, enriched with β-glucan, in metabolic biomarkers of healthy participants.
Detailed description
A pilot cross-over, controlled, randomized and single-blinded, intervention-clinical trial was carried out, in twelve healthy men and women, aged nineteen to sixty-five years, after random allocation into the control, the grape and the barley interventional groups, received a high-fat and high-carbohydrate meal, containing wheat flour or wheat and 10% grape seed flour or wheat and 40% barley flour, enriched with β-glucan, crackers. Participants consumed the same meals, allocating in cross-over order, with 1 washout week after each trial period. Differences on the metabolism of postprandial serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Functional crackers enriched with grape seed flour | The crackers was enriched with 10% grape seed flour |
| OTHER | Functional crackers with 40% barley flour and enriched with β-glucans | The crackers consisted of 60% wheat flour, 40% barley flour and was enriched with β-glucans. |
Timeline
- Start date
- 2023-02-15
- Primary completion
- 2023-10-01
- Completion
- 2024-01-15
- First posted
- 2023-08-04
- Last updated
- 2023-11-30
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT05977543. Inclusion in this directory is not an endorsement.